October 27, 2008 / 1:59 PM / 9 years ago

UPDATE 1-Barr gets FDA nod for oral contraceptive

(Recasts; adds details)

Oct 27 (Reuters) - Barr Pharmaceuticals Inc BRL.N said the U.S. regulators approved an oral contraceptive made by its unit Duramed Pharmaceuticals Inc.

Barr, which agreed to be bought by Israel-based Teva Pharmaceutical Industries Ltd TEVA.O for $7.46 billion in July, said the drug, LoSeasonique, would be available by prescription to women in the first quarter of 2009. The drug’s extended-cycle regimen, indicated for prevention of pregnancy, is designed to reduce the number of withdrawal bleeding periods from 13 to four per year, the company said in a statement.

Withdrawal bleeding is experienced each month when a woman uses a hormonal birth control method.

Shares of Barr were down 56 cents at $58.58 in early morning trade on the New York Stock Exchange. (Reporting by Esha Dey in Bangalore; Editing by Anil D‘Silva;)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below